Cargando…
Covid-19 and drug therapy, what we learned
COVID-19, the disease associated in December 2019 with the novel coronavirus SARS-CoV-2, was observed for the first time in China and then spread worldwide becoming pandemic. Currently, there is still no licensed specific antiviral treatment for the human coronavirus disease and a vaccine will not b...
Autores principales: | Provenzani, Alessio, Polidori, Piera |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203261/ https://www.ncbi.nlm.nih.gov/pubmed/32382873 http://dx.doi.org/10.1007/s11096-020-01049-6 |
Ejemplares similares
-
Evaluation of treatment of invasive fungal infections
por: Casucci, Ilenia, et al.
Publicado: (2014) -
Evidence-based application of explicit criteria to assess the appropriateness of geriatric prescriptions at admission and hospital stay
por: Di Martino, Enrica, et al.
Publicado: (2020) -
What will we choose to learn from the COVID-19 pandemic?
por: Bayingana, Alice Uwase, et al.
Publicado: (2021) -
Stresses and anxieties in the time of the COVID-19 pandemic — what we can learn
por: Ayyala, Rama S., et al.
Publicado: (2020) -
COVID-19 and patient engagement in health research: What have we learned?
por: Denegri, Simon, et al.
Publicado: (2021)